Mymetics Corp (MYMX)

[Work Harder]

Antibody findings spark ideas for pan-coronavirus vaccine

and the senior scientists were David Veesler

The project was also partially funded by the Swiss Kidney Foundation.

https://newsroom.uw.edu/news/antibody-findings-spark-ideas-pan-coronavirus-vaccine

Humabs BioMed, a subsidiary of Vir Biotechnology is a leading Swiss antibody therapeutics company that discovers and develops superior antibodies directly derived from individuals who have successfully overcome major diseases.

https://www.swissbiotech.org/listing/humabs-biomed-ag/

https://pitchbook.com/profiles/company/169566-04#comparisons

https://www.vir.bio/contact/

Vir and partner GSK are pleased to share that new preclinical live virus data support pseudovirus testing demonstrating that our investigational monoclonal antibody retains activity against all tested SARS-CoV-2 variants of concern, including Delta and Omicron.

https://www.vir.bio/

17 November 2021

GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment

https://www.gsk.com/en-gb/media/press-releases/gsk-and-vir-biotechnology-announce-united-states-government-agreements-to-purchase-sotrovimab-a-covid-19-treatment/

Dr. Lanzavecchia worked for almost two decades at the Basel Institute for Immunology. He has been a professor at the University of Genova and at the Swiss Federal Institute of Technology, ETH Zurich.

https://www.vir.bio/team/antonio-lanzavecchia/

Basel King

lol

After the pandemic: perspectives on the future trajectory of COVID-19

https://pubmed.ncbi.nlm.nih.gov/34237771/